Search for content, post, videos

Oncopeptides appoints new interim CFO

CFO

Oncopeptides has appointed Annika Muskantor as interim Chief Financial Officer, CFO.

Muskantor has an extensive experience as interim CFO from a broad range of industries including the life science industry, and she assumed her position on November 8. The appointment follows the previously announced resignation by CFO Anders Martin-Löf.

Photo: iStock